|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
|
US5877193A
(en)
|
1996-07-19 |
1999-03-02 |
Hoffmann-La Roche Inc. |
Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
|
|
EP0981327B1
(en)
|
1997-05-07 |
2002-11-06 |
Galen (Chemicals) Limited |
Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
|
|
CA2349832A1
(en)
|
1999-01-13 |
2000-07-20 |
Warner-Lambert Company |
Benzenesulfonamide derivatives and their use as mek inhibitors
|
|
JP2003504401A
(ja)
|
1999-07-16 |
2003-02-04 |
ワーナー−ランバート・カンパニー |
Ｍｅｋ阻害剤を用いる慢性疼痛の治療方法
|
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
|
FR2836917B1
(fr)
|
2002-03-11 |
2006-02-24 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif
|
|
BR0312023A
(pt)
|
2002-06-27 |
2005-03-22 |
Novo Nordisk As |
Composto, composto ativador da glicose cinase, método para evitar a hipoglicemia, uso de um composto, e, composição farmacêutica
|
|
WO2004092123A2
(en)
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
|
JP2009513523A
(ja)
|
2003-07-08 |
2009-04-02 |
ノバルティス アクチエンゲゼルシャフト |
ベンゼンスルホニルアミノ化合物およびそれらを含む医薬組成物
|
|
US8202861B2
(en)
|
2003-08-08 |
2012-06-19 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of voltage-gated sodium channels
|
|
HU227684B1
(en)
|
2003-08-29 |
2011-11-28 |
Sanofi Aventis |
Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
|
|
JP2008524244A
(ja)
|
2004-12-17 |
2008-07-10 |
タケダ サン ディエゴ インコーポレイテッド |
水酸化ステロイド脱水素酵素阻害剤
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
CA2624726A1
(en)
|
2005-10-06 |
2007-04-12 |
Sanofi-Aventis |
4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
|
|
NZ593074A
(en)
|
2005-12-21 |
2012-04-27 |
Vertex Pharma |
sulfonamide-pyrrolidone derivatives as Modulators of Ion Channels
|
|
EP2054385A2
(en)
|
2006-08-15 |
2009-05-06 |
F. Hoffmann-Roche AG |
Phenyl, pyridine and quinoline derivatives
|
|
US7968556B2
(en)
|
2006-10-19 |
2011-06-28 |
Signal Pharmaceuticals, Llc |
Heteroaryl compounds, compositions thereof, and methods of treatment therewith
|
|
CA2693588C
(en)
|
2007-07-13 |
2015-11-17 |
Icagen, Inc. |
Sodium channel inhibitors
|
|
US8853250B2
(en)
|
2007-07-13 |
2014-10-07 |
Icagen, Inc. |
Sodium channel inhibitors
|
|
WO2009013171A2
(en)
|
2007-07-24 |
2009-01-29 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
US7935779B2
(en)
|
2008-03-07 |
2011-05-03 |
Great Eastern Resins Industrial Co., Ltd. |
Synthesis of polyimides (PI) from poly-carbodiimides and dianhydrides by sequential self-repetitive reaction (SSRR)
|
|
NZ588983A
(en)
|
2008-06-25 |
2011-11-25 |
Daiichi Sankyo Co Ltd |
Carboxylic acid compound
|
|
RU2011103451A
(ru)
|
2008-07-01 |
2012-08-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Гетероциклические производные в качестве модуляторов ионных каналов
|
|
GB0815947D0
(en)
|
2008-09-02 |
2008-10-08 |
Univ Dundee |
Compounds
|
|
WO2010029300A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Bis aromatic compounds for use in the treatment of inflammation
|
|
HUE025013T2
(hu)
|
2009-01-12 |
2016-04-28 |
Pfizer Ltd |
Szulfonamid-származékok
|
|
WO2012004743A1
(en)
|
2010-07-09 |
2012-01-12 |
Pfizer Limited |
Benzenesulfonamides useful as sodium channel inhibitors
|
|
EP2606051B1
(en)
|
2010-08-20 |
2016-10-05 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
|
MX2014001851A
(es)
|
2011-08-17 |
2014-10-24 |
Amgen Inc |
Inhibidores del canal de heteroarilo sodio.
|
|
JP2014532660A
(ja)
|
2011-10-28 |
2014-12-08 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
電位作動型ナトリウムチャネルにおける選択活性を有するベンゾオキサゾリノン化合物
|
|
RU2014121984A
(ru)
|
2011-10-31 |
2015-12-10 |
Ксенон Фармасьютикалз Инк. |
Бензолсульфонамидные соединения и их применение в качестве терапевтических средств
|
|
JP6014155B2
(ja)
|
2011-10-31 |
2016-10-25 |
ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
ビアリールエーテルスルホンアミドおよび治療剤としてのそれらの使用
|
|
US8889741B2
(en)
|
2012-02-09 |
2014-11-18 |
Daiichi Sankyo Company, Limited |
Cycloalkane derivatives
|
|
US9346798B2
(en)
|
2012-02-13 |
2016-05-24 |
Amgen Inc. |
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
|
|
KR102038607B1
(ko)
|
2012-10-15 |
2019-10-30 |
주식회사 대웅제약 |
소디움 채널 차단제, 이의 제조방법 및 이의 용도
|
|
JP2015535252A
(ja)
|
2012-10-26 |
2015-12-10 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
電位作動型ナトリウムチャネルにおいて選択的活性を有するｎ−置換インダゾールスルホンアミド化合物
|
|
EP2911668A4
(en)
|
2012-10-26 |
2016-07-20 |
Merck Sharp & Dohme |
BENZOXAZOLINONE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-CONTROLLED SODIUM CHANNELS
|
|
TW201443025A
(zh)
|
2013-04-19 |
2014-11-16 |
Pfizer Ltd |
化學化合物
|
|
TW201512171A
(zh)
|
2013-04-19 |
2015-04-01 |
Pfizer Ltd |
化學化合物
|
|
WO2014201173A1
(en)
|
2013-06-12 |
2014-12-18 |
Amgen Inc. |
Bicyclic sulfonamide compounds as sodium channel inhibitors
|
|
GB201310542D0
(en)
|
2013-06-13 |
2013-07-31 |
Antabio Sas |
Compounds
|
|
JP6407285B2
(ja)
|
2013-09-09 |
2018-10-17 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
ＲＯＲγ調節因子
|
|
UA120353C2
(uk)
|
2013-09-10 |
2019-11-25 |
Хромоселл Корпорейшн |
Модулятори натрієвого каналу для лікування болю і діабету
|
|
WO2015077905A1
(en)
|
2013-11-29 |
2015-06-04 |
Merck Sharp & Dohme Corp. |
Bicycloamine-substituted-n-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
AU2014370407B2
(en)
|
2013-12-23 |
2018-03-29 |
Purdue Pharma L.P. |
Indazoles and use thereof
|
|
WO2016177340A1
(zh)
|
2015-05-05 |
2016-11-10 |
上海海雁医药科技有限公司 |
双环取代的苯磺酰胺衍生物、其制法与医药上的用途
|
|
US10519147B2
(en)
|
2015-12-18 |
2019-12-31 |
Merck Sharp & Dohme Corp. |
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
AU2016370554B2
(en)
|
2015-12-18 |
2018-11-29 |
Merck Sharp & Dohme Corp. |
Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
CN114984003B
(zh)
|
2016-05-03 |
2024-08-27 |
拜耳制药股份公司 |
芳族磺酰胺衍生物
|
|
PL3458449T3
(pl)
|
2016-05-20 |
2025-06-23 |
Xenon Pharmaceuticals Inc. |
Związki benzenosulfonamidowe i ich zastosowanie jako środki terapeutyczne
|
|
WO2018093694A1
(en)
|
2016-11-17 |
2018-05-24 |
Merck Sharp & Dohme Corp. |
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
CN110325531B
(zh)
*
|
2016-12-09 |
2022-05-27 |
泽农医药公司 |
苯磺酰胺及其作为治疗剂的用途
|
|
US10710994B2
(en)
|
2018-03-19 |
2020-07-14 |
Genentech, Inc. |
Oxadiazole transient receptor potential channel inhibitors
|
|
US10745392B2
(en)
|
2018-06-13 |
2020-08-18 |
Xenon Pharmaceuticals Inc. |
Benzenesulfonamide compounds and their use as therapeutic agents
|
|
JP7447089B2
(ja)
|
2018-08-31 |
2024-03-11 |
サイトキネティックス， インコーポレイテッド |
心筋サルコメア阻害剤
|
|
MA53488A
(fr)
|
2018-08-31 |
2021-12-08 |
Xenon Pharmaceuticals Inc |
Composés de sulfonamide substitués par hétéroaryle et leur utilisation en tant qu'inhibiteurs de canaux sodiques
|
|
KR20210054510A
(ko)
|
2018-08-31 |
2021-05-13 |
제논 파마슈티칼스 인크. |
헤테로아릴-치환된 술폰아미드 화합물 및 치료제로서의 그의 용도
|